An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/07/200714171338.htm
No comments:
Post a Comment